Hangzhou Zhongmei Huadong Pharm. Co. Ltd.

Hangzhou Zhongmei Huadong Pharm. Co. Ltd.

About

Company description

Our company is a large-scale comprehensive group owning a public stock company (Huadong Medicine Co Ltd), several joint ventures (Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd, Hangzhou MSD Pharmaceutical Co Ltd, Hangzhou Jiuyuan Gene Engineering Co Ltd, Zhejiang Huayi Pharmaceutical Co Ltd and Zhejiang ESTEVE-HUAYI Pharmaceutical Co Ltd) and series of share-holder pharmaceutical and chemical companies.

We are manufacturers of Dosages, APIs and intermediates by fermentation, synthesis and biotechnology, especially in the area of immunosuppressant and anti-diobetic agents. Our main products include: Acarbose, Cyclosporine, Febuxostat, Mycophenolate Mofetil, Orlistat, Sirolimus, Tacrolimus, Everolimus, etc. and series of finishend dosage, including tablets, capsules, injection, oral solution.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: API Contract Manufacturing |Excipients More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 20H13 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 61B13 See our Exhibitor Profile   See full Exhibitor List
12 mar 2019

CPhI South East Asia 2019

12-14 March 2019 Bangkok, Thailand We were at stand B8 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Hangzhou Zhongmei Huadong Pharm. Co. Ltd.

Hangzhou Zhongmei Huadong Pharm. Co. Ltd.

Contact information

Address

Telephone

Website

View all contact information